Search for Clinical Trial Results
Colitis, Ulcerative - 25 Studies Found
Status | Study |
Terminated |
Study Name: Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2013-09-24 Interventions:
|
Completed |
Study Name: Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2009-12-17 Interventions: Drug: GSK1399686 Each dose level of GSK1399686 will be subsequently tested in a cohort of approximately |
Withdrawn |
Study Name: A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2012-05-24 Interventions:
|
Completed |
Study Name: A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis. Condition: Colitis, Ulcerative Date: 2013-05-23 Interventions:
|
Completed |
Study Name: A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis Condition: Date: 2024-06-15 |
Completed |
Study Name: A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2013-11-14 Interventions: Biological: Golimumab SC injections Other Name: SIMP |
Terminated |
Study Name: Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients Condition: Colitis, Ulcerative Date: 2014-09-19 Interventions:
|
Active, not recruiting |
Study Name: An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2015-11-06 Interventions: Drug: GED-0301 Other Name: Mongersen |
Terminated |
Study Name: Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis. Condition: Colitis, Ulcerative Date: 2013-11-27 Interventions: Drug: GSK2586184 400mg White film coated round biconvex GSK2586184 200 mg tablets, administered 2 X twic |
Completed |
Study Name: Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) Condition: Colitis, Ulcerative Date: 2008-09-03 Interventions:
|